… “vaccine efficacy”, “HIV vaccine trial”, and “HIV vaccine clinical study” for HIV vaccine efficacy
… We did not identify any previous studies of HIV vaccines showing efficacy. There was no …

… vaccine trial using the MF59 adjuvant rather than Alum with … the relative efficacy of identical
ALVAC-HIV B/C HIV vaccines with Alum … reason for the decreased vaccine efficacy, via lower …

… is essential to eradicating human immunodeficiency virus (HIV) infection. A canarypox–protein
HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/E) showed modest efficacy in …

… Although our study provided preliminary evidence that an HIV vaccine regimen has the … :
vaccine efficacy may have decreased over the first year after vaccination, and vaccine efficacy …

… RV144 consisted of giving ALVAC at weeks 0 and 4, and then ALVAC and AIDSVAX at weeks
12 and 24. The study was done in Thailand and resulted in a vaccine efficacy of 31·2% (p=…

… multiple HIV… HIV vaccines that show efficacy, however, the results support continued dissection
of Ab responses to the V2 region which may illuminate mechanisms of protection from HIV…

… Modest efficacy was reported for the HIV vaccine tested in the RV144 trial, … (ALVAC) and
envelope (env) glycoprotein (gp120). These vaccine components were adapted to express HIV-…

… vaccine efficacy (VE P ) as the percent reduction (vaccine vs … should also be considered
in HIV vaccine trials and is part of … will provide further insight for HIV vaccine development. …

… regimens have reached Phase IIB or Phase III efficacy … put the efficacy and immunogenicity
results of HIV vaccine trials in … covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (…

… of antiviral efficacy for protection against pathogenic organisms [23–25] . We speculated
that the ALVAC-HIV vaccine may have modulated the quality, rather than the quantity, of HIV-…